Skip to main content
Top
Published in: Journal of Experimental & Clinical Cancer Research 1/2011

Open Access 01-12-2011 | Research

The Zfx gene is expressed in human gliomas and is important in the proliferation and apoptosis of the human malignant glioma cell line U251

Authors: Youxin Zhou, Zuopeng Su, Yulun Huang, Ting Sun, Sansong Chen, Tingfeng Wu, Guilin Chen, Xueshun Xie, Bin Li, Ziwei Du

Published in: Journal of Experimental & Clinical Cancer Research | Issue 1/2011

Login to get access

Abstract

Background

Zfx is a zinc finger protein of the Zfy family, whose members are highly conserved in vertebrates. Zfx is a shared transcriptional regulator of both embryonic stem cells (ESC) and hematopoietic stem cells (HSC), which suggests a common genetic basis of self-renewal in embryonic and adult stem cells. The level of Zfx expression correlates with aggressiveness and severity in many cancer types, including prostate cancer, breast cancer, and leukemia. However, the importance of Zfx in human glioma is largely unknown. In the present study, we examined the role of Zfx in human glioma.

Methods

We detected expression levels of Zfx mRNA in U251 cells, U87 cells, U373 cells, and A172 cells by semi-quantitative RT-PCR. To analyze the expression of Zfx mRNA in glioma tissues, we performed real-time quantitative PCR on 35 pathologically confirmed glioma samples (Grade I-4cases, Grade II-13cases, Grade III-11cases, and Grade IV-7cases) and on 5 noncancerous brain tissue samples. We used lentivirus-mediated small interfering RNAs (siRNAs) to knock down Zfx expression in the human malignant glioma cell line U251. Changes in Zfx target gene expression were determined by real-time RT-PCR. Cell proliferation was examined by a High Content Screening assay. DNA synthesis in proliferating cells was determined by BrdU incorporation. Cell cycle distribution and apoptosis were detected by flowcytometric analysis.

Results

We discovered that Zfx mRNA was expressed in U251 cells, U87 cells, U373 cells, and A172 cells. The expression level of Zfx is significantly higher in gliomas compared to noncancerous brain tissue. Using a lentivirus-based RNAi approach, Zfx expression was significantly inhibited in human glioblastoma U251 cells. The effects of Zfx knockdown on cell proliferation, cell cycle distribution, and apoptosis were assessed. Inhibition of Zfx expression in U251 cells by RNAi significantly impaired cell proliferation, increased apoptosis, and arrested cells in S phase.

Conclusions

The results of our study demonstrate that the Zfx gene is highly expressed in glioma tissue and in glioma cell lines. Furthermore, Zfx may play a critical role in cell proliferation, cell cycle distribution, and apoptosis of human malignant glioma cells.
Appendix
Available only for authorised users
Literature
1.
go back to reference Surawicz TS, McCarthy BJ, Kupelian V, Jukich PJ, Bruner JM, Davis FG: Descriptive epidemiology of primary brain and CNS tumors: results from the Central Brain Tumor Registry of the United States, 1990-1994. Neuro Oncol. 1999, 1: 14-25.PubMedCentralPubMed Surawicz TS, McCarthy BJ, Kupelian V, Jukich PJ, Bruner JM, Davis FG: Descriptive epidemiology of primary brain and CNS tumors: results from the Central Brain Tumor Registry of the United States, 1990-1994. Neuro Oncol. 1999, 1: 14-25.PubMedCentralPubMed
2.
go back to reference Prados MD, Levin V: Biology and treatment of malignant glioma. Semin Oncol. 2000, 27: 1-10.PubMed Prados MD, Levin V: Biology and treatment of malignant glioma. Semin Oncol. 2000, 27: 1-10.PubMed
3.
go back to reference Wechsler-Reya R, Scott MP: The developmental biology of brain tumors. Annu Rev Neurosci. 2001, 24: 385-428. 10.1146/annurev.neuro.24.1.385.CrossRefPubMed Wechsler-Reya R, Scott MP: The developmental biology of brain tumors. Annu Rev Neurosci. 2001, 24: 385-428. 10.1146/annurev.neuro.24.1.385.CrossRefPubMed
5.
go back to reference Ballman KV, Buckner JC, Brown PD, Giannini C, Flynn PJ, LaPlant BR, Jaeckle KA: The relationship between six-month progression-free survival and 12-month overall survival end points for phase II trials in patients with glioblastoma multiforme. Neuro Oncol. 2007, 9: 29-38.PubMedCentralCrossRefPubMed Ballman KV, Buckner JC, Brown PD, Giannini C, Flynn PJ, LaPlant BR, Jaeckle KA: The relationship between six-month progression-free survival and 12-month overall survival end points for phase II trials in patients with glioblastoma multiforme. Neuro Oncol. 2007, 9: 29-38.PubMedCentralCrossRefPubMed
6.
go back to reference Surawicz TS, Davis F, Freels S, Laws ER, Menck HR: Brain tumor survival:results from the national cancer data base. J Neurooncol. 1998, 40: 151-160. 10.1023/A:1006091608586.CrossRefPubMed Surawicz TS, Davis F, Freels S, Laws ER, Menck HR: Brain tumor survival:results from the national cancer data base. J Neurooncol. 1998, 40: 151-160. 10.1023/A:1006091608586.CrossRefPubMed
7.
go back to reference Schneider-Gädicke A, Beer-Romero P, Brown LG, Mardon G, Luoh SW, Page DC: Putative transcription activator with alternative isoforms encoded by human ZFX gene. Nature. 1989, 342: 708-711. 10.1038/342708a0.CrossRefPubMed Schneider-Gädicke A, Beer-Romero P, Brown LG, Mardon G, Luoh SW, Page DC: Putative transcription activator with alternative isoforms encoded by human ZFX gene. Nature. 1989, 342: 708-711. 10.1038/342708a0.CrossRefPubMed
8.
go back to reference Jason Kam, Gresshoff Peter M, Shorter Ray: The Q-type C2H2 zinc finger subfamily of transcription factors in Triticum aestivum is predominantly expressed in roots and enriched with members containing an EAR repressor motif and responsive to drought stress. Plant Mol Biol. 2008, 67: 305-322. 10.1007/s11103-008-9319-3.CrossRef Jason Kam, Gresshoff Peter M, Shorter Ray: The Q-type C2H2 zinc finger subfamily of transcription factors in Triticum aestivum is predominantly expressed in roots and enriched with members containing an EAR repressor motif and responsive to drought stress. Plant Mol Biol. 2008, 67: 305-322. 10.1007/s11103-008-9319-3.CrossRef
9.
go back to reference Chandrasekharan S, Kumar S, Valley CM, Rai A: Proprietary science, open science and the role of patent disclosure: the case of zinc-finger proteins. Nat Biotechnol. 2009, 27: 140-144. 10.1038/nbt0209-140.PubMedCentralCrossRefPubMed Chandrasekharan S, Kumar S, Valley CM, Rai A: Proprietary science, open science and the role of patent disclosure: the case of zinc-finger proteins. Nat Biotechnol. 2009, 27: 140-144. 10.1038/nbt0209-140.PubMedCentralCrossRefPubMed
10.
go back to reference Schnidar H, Eberl M, Klingler S, Mangelberger D, Kasper M, Hauser-Kronberger C, Regl G, Kroismayr R, Moriggl R, Sibilia M, Aberger F: Epidermal growth factor receptor signaling synergizes with Hedgehog/GLI in oncogenic transformation via activation of the MEK/ERK/JUN pathway. Cancer Res. 2009, 69: 1284-1292. 10.1158/0008-5472.CAN-08-2331.PubMedCentralCrossRefPubMed Schnidar H, Eberl M, Klingler S, Mangelberger D, Kasper M, Hauser-Kronberger C, Regl G, Kroismayr R, Moriggl R, Sibilia M, Aberger F: Epidermal growth factor receptor signaling synergizes with Hedgehog/GLI in oncogenic transformation via activation of the MEK/ERK/JUN pathway. Cancer Res. 2009, 69: 1284-1292. 10.1158/0008-5472.CAN-08-2331.PubMedCentralCrossRefPubMed
11.
go back to reference Naldini L, Gallay P, Gallay P: In vivo gene delivery and stable transduction of nondividing cells by a lentiviral vector system. Science. 1996, 272: 263-7. 10.1126/science.272.5259.263.CrossRefPubMed Naldini L, Gallay P, Gallay P: In vivo gene delivery and stable transduction of nondividing cells by a lentiviral vector system. Science. 1996, 272: 263-7. 10.1126/science.272.5259.263.CrossRefPubMed
12.
go back to reference Galan-Caridad JM, Harel S, Arenzana TL, Hou ZE, Doetsch FK, Mirny LA, Reizis B: Zfx controls the self-renewal of embryonic and hematopoietic stem cells. Cell. 2007, 129: 345-357. 10.1016/j.cell.2007.03.014.PubMedCentralCrossRefPubMed Galan-Caridad JM, Harel S, Arenzana TL, Hou ZE, Doetsch FK, Mirny LA, Reizis B: Zfx controls the self-renewal of embryonic and hematopoietic stem cells. Cell. 2007, 129: 345-357. 10.1016/j.cell.2007.03.014.PubMedCentralCrossRefPubMed
13.
go back to reference Hu G, Kim J, Xu Q, Leng Y, Orkin SH, Elledge SJ: A genome-wide RNAi screen identifies a new transcriptional module required for self-renewal. Genes Dev. 2009, 23: 837-848. 10.1101/gad.1769609.PubMedCentralCrossRefPubMed Hu G, Kim J, Xu Q, Leng Y, Orkin SH, Elledge SJ: A genome-wide RNAi screen identifies a new transcriptional module required for self-renewal. Genes Dev. 2009, 23: 837-848. 10.1101/gad.1769609.PubMedCentralCrossRefPubMed
14.
go back to reference Arenzana TL, Smith-Raska MR, Reizis B: Transcription factor Zfx controls BCR-induced proliferation and survival of B lymphocytes. Blood. 2009, 113: 5857-5867. 10.1182/blood-2008-11-188888.PubMedCentralCrossRefPubMed Arenzana TL, Smith-Raska MR, Reizis B: Transcription factor Zfx controls BCR-induced proliferation and survival of B lymphocytes. Blood. 2009, 113: 5857-5867. 10.1182/blood-2008-11-188888.PubMedCentralCrossRefPubMed
15.
go back to reference Sakhinia E, Glennie C, Hoyland JA, Menasce LP, Brady G, Miller C, Radford JA, Byers RJ: Clinical quantitation of diagnostic and predictive gene expression levels in follicular and diffuse large B-cell lymphoma by RT-PCR gene expression profiling. Blood. 2007, 109: 3922-3928. 10.1182/blood-2006-09-046391.CrossRefPubMed Sakhinia E, Glennie C, Hoyland JA, Menasce LP, Brady G, Miller C, Radford JA, Byers RJ: Clinical quantitation of diagnostic and predictive gene expression levels in follicular and diffuse large B-cell lymphoma by RT-PCR gene expression profiling. Blood. 2007, 109: 3922-3928. 10.1182/blood-2006-09-046391.CrossRefPubMed
16.
go back to reference Huang D, Gao Q, Guo L, Zhang C, Jiang W, Li H, Wang J, Han X, Shi Y, Lu SH: Isolation and identification of cancer stem-like cells in esophageal carcinoma cell lines. Stem Cells Dev. 2009, 18: 465-473. 10.1089/scd.2008.0033.CrossRefPubMed Huang D, Gao Q, Guo L, Zhang C, Jiang W, Li H, Wang J, Han X, Shi Y, Lu SH: Isolation and identification of cancer stem-like cells in esophageal carcinoma cell lines. Stem Cells Dev. 2009, 18: 465-473. 10.1089/scd.2008.0033.CrossRefPubMed
17.
go back to reference Sherr CJ: Growth factor-regulated G1 cyclins. Stem Cells. 1994, 12: 47-55.PubMed Sherr CJ: Growth factor-regulated G1 cyclins. Stem Cells. 1994, 12: 47-55.PubMed
18.
go back to reference Sherr CJ: The Pezcoller lecture: cancer cell cycles revisited. Cancer Res. 2000, 60: 3689-3695.PubMed Sherr CJ: The Pezcoller lecture: cancer cell cycles revisited. Cancer Res. 2000, 60: 3689-3695.PubMed
19.
go back to reference Tessema M, Lehmann U, Kreipe H: Cell cycle and no end. Virchows Arch. 2004, 444: 313-323. 10.1007/s00428-003-0971-3.CrossRefPubMed Tessema M, Lehmann U, Kreipe H: Cell cycle and no end. Virchows Arch. 2004, 444: 313-323. 10.1007/s00428-003-0971-3.CrossRefPubMed
20.
go back to reference Gonze D, Goldbeter A: A model for a network of phosphorylation-dephosphorylation cycles displaying the dynamics of dominoes and clocks. J Theor Biol. 2001, 210: 167-186. 10.1006/jtbi.2000.2294.CrossRefPubMed Gonze D, Goldbeter A: A model for a network of phosphorylation-dephosphorylation cycles displaying the dynamics of dominoes and clocks. J Theor Biol. 2001, 210: 167-186. 10.1006/jtbi.2000.2294.CrossRefPubMed
21.
go back to reference Dingli D, Michor F: Successful therapy must eradicate cancer stem cells. Stem Cells. 2006, 24: 2603-2610. 10.1634/stemcells.2006-0136.CrossRefPubMed Dingli D, Michor F: Successful therapy must eradicate cancer stem cells. Stem Cells. 2006, 24: 2603-2610. 10.1634/stemcells.2006-0136.CrossRefPubMed
22.
go back to reference Singh SK, Clarke ID, Hide T, Dirks PB: Cancer stem cells in nervous system tumors. Oncogene. 2004, 23: 7267-7273. 10.1038/sj.onc.1207946.CrossRefPubMed Singh SK, Clarke ID, Hide T, Dirks PB: Cancer stem cells in nervous system tumors. Oncogene. 2004, 23: 7267-7273. 10.1038/sj.onc.1207946.CrossRefPubMed
23.
go back to reference Harris MA, Yang H, Low BE, Mukheriee J, Guha A, Bronson RT, Shultz LD, Lsrael MA, Yun K: Cancer stem cells are enriched in the side population cells in a mouse model of glioma. Cancer Res. 2008, 68: 10051-10059. 10.1158/0008-5472.CAN-08-0786.PubMedCentralCrossRefPubMed Harris MA, Yang H, Low BE, Mukheriee J, Guha A, Bronson RT, Shultz LD, Lsrael MA, Yun K: Cancer stem cells are enriched in the side population cells in a mouse model of glioma. Cancer Res. 2008, 68: 10051-10059. 10.1158/0008-5472.CAN-08-0786.PubMedCentralCrossRefPubMed
Metadata
Title
The Zfx gene is expressed in human gliomas and is important in the proliferation and apoptosis of the human malignant glioma cell line U251
Authors
Youxin Zhou
Zuopeng Su
Yulun Huang
Ting Sun
Sansong Chen
Tingfeng Wu
Guilin Chen
Xueshun Xie
Bin Li
Ziwei Du
Publication date
01-12-2011
Publisher
BioMed Central
Published in
Journal of Experimental & Clinical Cancer Research / Issue 1/2011
Electronic ISSN: 1756-9966
DOI
https://doi.org/10.1186/1756-9966-30-114

Other articles of this Issue 1/2011

Journal of Experimental & Clinical Cancer Research 1/2011 Go to the issue
Webinar | 19-02-2024 | 17:30 (CET)

Keynote webinar | Spotlight on antibody–drug conjugates in cancer

Antibody–drug conjugates (ADCs) are novel agents that have shown promise across multiple tumor types. Explore the current landscape of ADCs in breast and lung cancer with our experts, and gain insights into the mechanism of action, key clinical trials data, existing challenges, and future directions.

Dr. Véronique Diéras
Prof. Fabrice Barlesi
Developed by: Springer Medicine